News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • House Republicans blocked Democrats' bid to halt U.S. strikes on Iran, preserving current military-authority dynamics and keeping geopolitical risk elevated.
  • IMF chief Kristalina Georgieva urged central banks to weigh energy-driven inflation against weakening demand, implying a more cautious monetary policy path.
  • Large, timed bets ahead of Trump policy announcements moved crude, Treasury yields and equities and are now under scrutiny for possible misuse of information.
  • Paramount Skydance secured syndicated financing for its Warner Bros deal, leaving the merged company with just under $80 billion in net debt.
  • Tesla is developing a lower-cost compact EV to boost volumes, a move likely to increase sales but further compress automotive margins.
  • UBS named Permian Resources, Diamondback, Chord Energy and California Resources as best positioned to gain from ongoing oil-and-gas consolidation.

Latest Articles

Nanox Signs Distribution Agreement with Elite Surgical Technologies to Deploy Nanox.ARC in Key U.S. Markets

Nanox Signs Distribution Agreement with Elite Surgical Technologies to Deploy Nanox.ARC in Key U.S. Markets

Nano-X Imaging Ltd. (NASDAQ: NNOX) announced a distribution agreement with Elite Surgical Technologies to deploy the Nanox.ARC digital tomosynthesis imaging system across five U.S. states, targeting orthopedic practices and post-surgical care settings. The partnership aims to enhance adoption of cost-effective, low-radiation 3D imaging to monitor b…

Calidi Biotherapeutics to Present New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Calidi Biotherapeutics to Present New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026

Calidi Biotherapeutics will present new data on its RedTail virotherapy platform at the AACR Annual Meeting 2026, highlighting its novel approach to simultaneously activate T-cells and induce high expression of T-cell engagers specifically in the tumor microenvironment. The company’s lead candidate, CLD-401, targets multiple solid tumors and is pro…

Tri Pointe Homes Named to 2026 Fortune 100 Best Companies to Work For® List, Honoring its Dedication to People-First Culture, Innovation, and Career Growth

Tri Pointe Homes Named to 2026 Fortune 100 Best Companies to Work For® List, Honoring its Dedication to People-First Culture, Innovation, and Career Growth

Tri Pointe Homes (NYSE: TPH), a major U.S. homebuilder, has been named to the 2026 Fortune 100 Best Companies to Work For list for the third time, recognizing its commitment to a people-first culture, innovation, and career growth. The company continues to enhance professional development, implement AI and technology initiatives, expand recruiting …

Apollo Funds Acquire Gatehouse Living Group from Gatehouse Bank

Apollo Funds Acquire Gatehouse Living Group from Gatehouse Bank

Apollo Global Management announced that funds it manages have acquired Gatehouse Living Group (GLG), a leading UK residential investment and property management platform, from Gatehouse Bank. The acquisition enhances Apollo's presence in the UK housing market, complementing its existing investments in UK homebuilding and mortgage lending. GLG will …

NOVAGOLD Files First Quarter 2026 Report Highlighting Growing Momentum on Key Donlin Gold Workstreams

NOVAGOLD Files First Quarter 2026 Report Highlighting Growing Momentum on Key Donlin Gold Workstreams

NOVAGOLD Resources Inc. reported significant progress in the first quarter of 2026 on its Donlin Gold project, highlighted by the launch of a Bankable Feasibility Study (BFS) led by Fluor Corporation and awarding strategic engineering contracts to advance critical infrastructure. The company completed an upsized private placement raising approximat…

Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx

Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx

Ardelyx, a US-based biopharmaceutical company, announced the appointment of Dr. Rajani Dinavahi as its new Chief Medical Officer. With over 20 years of experience in biotechnology and healthcare, Dr. Dinavahi will lead clinical development and medical affairs to strengthen Ardelyx's pipeline and advance its innovative medicines to market. This lead…

VivoSim Announces Pricing of up to a $4 Million Public Offering

VivoSim Announces Pricing of up to a $4 Million Public Offering

VivoSim Labs, a Nasdaq-listed biotech company specializing in next-generation New Approach Methodologies (NAMs) for preclinical safety testing using 3D human tissue models, has announced the pricing of a $4 million public offering. The offering comprises an initial $3 million closing and an additional $1 million tranche contingent on conditions suc…

Treasure Global’s Subsidiary Tadaa Technologies Partners with Anhui Fuyuan Group to Accelerate Global Drone and Electric Mobility Expansion

Treasure Global’s Subsidiary Tadaa Technologies Partners with Anhui Fuyuan Group to Accelerate Global Drone and Electric Mobility Expansion

Treasure Global Inc., a tech company listed on NASDAQ, announced a strategic partnership between its subsidiary Tadaa Technologies and Anhui Fuyuan Electromechanical Technology Co. Ltd. The partnership aims to establish a Malaysia-based hub focused on electric mobility solutions and military-grade drones targeting markets in Europe, North America, …

Watsco Declares $3.30 Quarterly Dividend

Watsco Declares $3.30 Quarterly Dividend

Watsco, Inc. has declared a $3.30 quarterly dividend, a 10% increase leading to an annual rate of $13.20 per share, payable April 30, 2026. The dividend hike signals confidence in Watsco's strong balance sheet and ongoing growth prospects in the North American HVAC/R distribution market. The company has a 52-year history of paying dividends and is …

Crane NXT Completes Acquisition of Antares Vision

Crane NXT Completes Acquisition of Antares Vision

Crane NXT, Co. finalized the acquisition of Antares Vision S.p.A., a leading company in detection, inspection, and traceability technologies. This acquisition broadens Crane NXT's portfolio, especially targeting the ~$3 billion life sciences and food & beverage sectors. Antares Vision has been delisted from Euronext Milan and is now a wholly owned …

Anterix and Texas-New Mexico Power Agreement Bolsters Grid Resiliency with Proven 900 MHz Private Wireless Platform

Anterix and Texas-New Mexico Power Agreement Bolsters Grid Resiliency with Proven 900 MHz Private Wireless Platform

Anterix has entered into a 900 MHz spectrum sale agreement with Texas-New Mexico Power (TNMP) to enable deployment of a mission-critical private wireless network aimed at improving grid reliability and outage response. This collaboration supports TNMP's System Resiliency Plan and aligns with a broader trend of Texas utilities adopting secure privat…

MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference

MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference

MiNK Therapeutics announced that an abstract on its investigational allogeneic invariant natural killer T (iNKT) cell therapy, agenT-797, has been accepted for presentation at the 2026 American Thoracic Society International Conference. The presentation will highlight a novel combination immunotherapy approach targeting severe and persistent infect…

Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset

Medicus Pharma Ltd Clarifies Positive SkinJect Phase 2 Dataset

Medicus Pharma Ltd. provided clarification on its Phase 2 clinical trial data for SkinJect, a doxorubicin-containing microneedle array for nodular basal cell carcinoma treatment. The company emphasized the therapeutic importance of the active drug arms over the device-only arm, highlighting that the 200µg dose cohort demonstrated the most promising…

Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines

Dyne Therapeutics Announces Participation at 2026 Academy of Managed Care Pharmacy (AMCP) Conference to Begin Shaping Access in US for Potential Neuromuscular Medicines

Dyne Therapeutics announced participation at the 2026 AMCP Conference with presentations on clinical trial data supporting their Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) therapeutics. The company is preparing for potential U.S. launches of DMD treatment next year and DM1 treatment in early 2028, focusing on payer engage…

RenX Enterprises Corp. Beats Revenue Guidance, Delivering $8.2 Million in Post-Acquisition Revenue While Completing Full Platform Buildout and Retiring $11.9 Million in Legacy Debt

RenX Enterprises Corp. Beats Revenue Guidance, Delivering $8.2 Million in Post-Acquisition Revenue While Completing Full Platform Buildout and Retiring $11.9 Million in Legacy Debt

RenX Enterprises Corp. reported fiscal year 2025 financial results, highlighting $8.2 million in post-acquisition revenue—17% above guidance—after acquiring Resource Group US Holdings LLC. The company completed the buildout of its Myakka City biomass processing facility, initiated deliveries into the premium compost market, retired $11.9 million in…